The state of the COA in 2026 and 2027

Supplier COAs: analytical gaps & regulatory reality

A certificate of analysis is a baseline claim, not a substitute for independent analytical testing.

Regulatory consensus, analytical chemists, and industry watchdogs universally agree: relying solely on a raw material supplier’s paperwork is a severe operational and legal liability.

Utility vs. liability

The limit of the supplier COA

The utility of a supplier COA

Identifies the specific analytical tests performed on a given lot.
Provides a baseline reference benchmark for your independent laboratory.
Establishes a traceable lot identifier for material provenance.

What it cannot do

Indemnify or cover the final products you label and distribute.
Discharge your independent quality assurance and final release obligations.
Make claims regarding safety or suitability.
Substitute for physical testing of the actual material delivered to your facility.

The analytical gap

What standard certificates omit

Most standard certificates stop at basic identity and a nominal purity figure. Rigorous incoming quality control demands tests frequently omitted due to cost:

Endotoxin (LAL): bacterial endotoxin load.
Heavy metals: lead, arsenic, cadmium, mercury.
Residual solvents: process solvents remaining from manufacture.
Impurity profiling: identification of secondary compounds.
Content assay: exact quantification of the labeled peptide’s mass.
Water content: residual moisture impacting mass formulation.
Counterion / salt form: specific salt state (acetate, TFA, HCl).
Bioburden / sterility: assessment of microbial load.

Regulatory & empirical evidence

Why paperwork alone does not hold

FDA and cGMP (21 CFR 211.84)

Quarantine is the default state for received material. The FDA mandates at least one specific confirmatory identity test on every incoming lot. A supplier’s COA cannot be substituted for independent receiving analysis without established validation. Read 21 CFR 211.84 at eCFR.

Empirical evidence (JAMA, 2017)

Independent analysis of 44 unapproved drug products sold online showed the paperwork failed to reflect physical reality 48% of the time, highlighting the statistical risk of bypassing independent testing. JAMA. 2017;318(20):2004–2010.

Document fraud & forgery

Independent testing facilities document widespread forgery of COAs by raw material suppliers. A static PDF holds no analytical weight unless verifiable via an accession number on the third-party laboratory’s secure server.

Pharmacopeial standard (USP <1083>)

USP standards forbid relying on a supplier’s COA for critical quality attributes unless the buyer has performed concurrent, independent laboratory testing on multiple lots to prove consistent accuracy.

We supply the material. You own the validation.

Comprehensive testing is expensive. This is why a complimentary PDF from a supplier cannot replace rigorous quality assurance. We price our inventory to ensure you have the operational margin to commission your own independent testing, apply your own branding, and build your business securely.

Open a Wholesale Account Incoming verification framework